ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1633	National Cancer Institute	Html	en	Acupuncture (PDQ®)–Health Professional Version	Expert-reviewed information summary about acupuncture as a treatment for people with cancer or cancer-related disorders.	acupuncture group 0.544956 acupuncture point injection 0.56675 different acupuncture styles 0.557087 acupuncture treatment sessions 0.54489 acupuncture treatments. 0.545813 Hand Acupuncture Therapy 0.545719 acupuncture treatment groups 0.559928 acupuncture points 0.588119 acupuncture therapy 0.563015 traditional acupuncture 0.548268 acupuncture point 0.596123 laser acupuncture 0.537252 trigger point acupuncture 0.547942 Acupuncture treatment points 0.566499 auricular acupuncture 0.588794 hand acupuncture 0.553522 scalp acupuncture 0.536815 needle acupuncture treatment 0.563009 microwave acupuncture 0.542417 Tradit Chin Med 0.692529 French acupuncture 0.546506 acupuncture intervention 0.539071 acupuncture treatment 0.701699	I. Acupuncture 0.548929 cancer pain 0.545512 antiemetic acupuncture point 0.541836 acupuncture treatment group 0.55583 limited acupuncture treatment 0.578929 acupuncture practice 0.552272 acupuncture analgesia 0.53661 acupuncture techniques 0.555209 Acupuncture devices 0.538698 breast cancer survivors 0.59422 relevant acupuncture points 0.559867 Acupuncture stimulation enhances 0.541189 acupuncture 0.900284 acupuncture treatment protocol 0.543974 American medical acupuncture 0.557696 acupuncture needles 0.571268 acupuncture needle usage 0.544037 French energetic acupuncture 0.555749 hot flashes 0.662063 classical acupuncture techniques 0.547726 standard acupuncture treatment 0.552322 constitutional acupuncture 0.545774 nose acupuncture 0.536571	CLICK HERE
1844	National Cancer Institute	Html	es	Tratamiento del cáncer de vías biliares (colangiocarcinoma) (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca del tratamiento del cáncer de vías biliares.	adjuvant chemotherapy 0.497068 Compton CC 0.455578 adjuvant chemotherapy useful 0.462157 bile ducts 0.908316 bile duct carcinomas 0.774332 inoperable carcinoma 0.476348 intrahepatic cholangiocarcinoma 0.503925 Sin embargo 0.470784 Definiciones TNM 0.476617 numerosas series 0.506838 7th ed 0.45537 improves survival after 0.45137 resected pancreaticobiliary carcinoma 0.499622 biliary tract cancer 0.575176 Radiat Oncol Biol 0.701902 external beam 0.48514 vías biliares estadio 0.564018 extrahepatic bile ducts 0.466498 Combined external beam 0.45221 patients with 0.492787 gallbladder carcinoma 0.510432 postoperative adjuvant chemotherapy 0.462347 Distal bile duct 0.448596 M0 T1 0.473506 surgical resection 0.452719	M0 T4 0.484822 M0 T3 0.485565 external beam radiotherapy 0.453326 Estadio TNM Descripción 0.522095 preoperative biliary 0.453311 external beam irradiation 0.452128 hilar cholangiocarcinoma 0.689926 conducto biliar distal 0.669242 Cancer Staging Manual 0.512502 Carcinoma indiferenciado.Tipos 0.498115 Surg Oncol 0.46427 New York 0.449054 Is postoperative adjuvant 0.451387 clasificación tnm 0.471721 Oncol Biol Phys 0.711839 biliar extrahepático distal 0.924726 Byrd DR 0.452521 0a estadio tnm 0.528327 M0 Tis 0.527937 Am Coll Surg 0.467573 plus s-1 chemotherapy 0.455855 AJCC Cancer Staging 0.522691 Edge SB 0.455654 plus gemcitabine versus 0.449075	CLICK HERE
2076	National Cancer Institute	Html	es	Alcohol y el riesgo de cáncer	Hoja informativa que resume la comprobación de la relación entre el consumo de alcohol y el riesgo de varios cánceres. Incluye información de los factores que afectan el riesgo de cánceres asociados con el alcohol, como son los genes y el uso de tabaco.	Neck Cancer Epidemiology 0.538614 Lancet Oncology 0.534891 Hirose K 0.511352 Matsuo K 0.510531 levadura fermenta azúcares 0.523222 pharyngeal cancers 0.510877 Alcohol drinking cessation 0.626157 British Journal 0.511017 vitamina a 0.51094 Straif K 0.510855 vitamina e 0.511443 IARC Monographs 0.512402 IARC Working Group 0.518509 riesgos resultantes 0.517271 Estados Unidos 0.591854 alcohol drinking 0.759868 Tajima K 0.511125 PubMed Abstract 0.957874 neck cancers 0.610459 Cancer Epidemiology 0.551257 Beral V 0.510723 Liver Disease 0.511887 cancer prevention 0.54975 alcohol consumption with 0.621668 vino tinto 0.531211	results from subgroup 0.518268 International Head 0.510721 Fedirko V 0.510662 contaminantes cancerígenos 0.510849 Carcinogenic Risks 0.530612 ADH hiperactiva 0.535244 Numerosos estudios 0.516257 preclinical studies 0.511192 enzima hiperactiva 0.522144 Bonifazi M 0.510536 epidemiological studies 0.512501 Hodgkin lymphoma 0.511109 enzima adh hiperactiva 0.532963 Tramacere I 0.552596 genetic polymorphisms 0.530043 enzima llamada 0.519065 Bagnardi V 0.51066 Rehm J 0.529488 cabo estudios 0.515059 pooled analysis 0.527827 renal cell carcinoma 0.521274 Cancer Institute 0.525901 células renales 0.53114 New York Academy 0.514614	CLICK HERE
2108	National Cancer Institute	Html	es	Prevención del cáncer de esófago (PDQ®)–Versión para profesionales de salud	Sumario de información revisada por expertos sobre los factores que pueden influir en el riesgo de cáncer de esófago y sobre la investigación dirigida a la prevención de esta enfermedad.	Engel LS 0.373609 Lindgren A 0.36811 upper gastrointestinal tract 0.346284 Cancer Research Fund 0.36332 double-blind intervention study 0.424218 Lagergren J 0.644302 Overholt BF 0.373783 American Cancer Society 0.556588 gastroesophageal reflux 0.530195 pooled analysis from 0.437305 Spechler SJ 0.373642 Kerlikowske K 0.370938 Symptomatic gastroesophageal reflux 0.441142 Instituto Nacional 0.401102 adenocarcinoma after antireflux 0.427487 Krewski D 0.370088 Sharma P 0.368176 Bergström R 0.435333 Chow WH 0.372718 with dysplasia 0.373025 Estados Unidos 0.417008 Natl Cancer Inst 0.801603 multi-site case-control study 0.44183 PDQ Prevención 0.356958 esophageal adenocarcinoma 0.994739	intestinal metaplasia 0.38046 Goyal RK 0.374621 Population attributable risks 0.444629 Siemiatycki J 0.370746 SEER Cancer Statistics 0.366598 Murray LJ 0.372685 Corley DA 0.666943 Muñoz N 0.361794 Cancer Facts 0.35503 gastric cancers 0.376055 cigarette smoking 0.377492 Norman Barrett 0.429462 Bang LJ 0.364677 National Cancer Institute 0.444849 Cancer Research 0.391943 gastric carcinoma 0.350615 Verma R 0.369649 Esophageal Adenocarcinoma Consortium 0.593225 Vaughan TL 0.552829 oesophageal adenocarcinoma 0.415979 Radiofrequency ablation 0.374836 systematic review 0.372952 estudios cohortes 0.383438 Franco E 0.368432	CLICK HERE
3436	National Cancer Institute	Html	es	Prevención del cáncer de estómago (gástrico) (PDQ®)–Versión para profesionales de salud	Sumario de información revisada por expertos sobre factores que pueden influir en el riesgo de presentar cáncer de estómago y sobre las investigaciones dirigidas a la prevención de esta enfermedad.	accessed july 0.333514 Chiaradia G 0.316124 pylori eradication treatment 0.329538 accessed march 0.316023 Causes Control 0.327021 Cancer Statistics Review 0.449494 Sin embargo 0.352357 American Cancer Society 0.453658 gastric lesions with 0.314929 Straif K 0.314594 Instituto Nacional 0.319677 IARC Working Group 0.33075 PDQ Exámenes 0.315741 Estados Unidos 0.320311 Natl Cancer Inst 0.573491 Fifteen-year effects 0.315673 biological agents 0.352496 PDQ Prevención 0.315154 gastric cancer incidence 0.458115 updated meta-analysis 0.316823 Nogueira A 0.314785 Cancer Epidemiology 0.329476 European Prospective Investigation 0.328359 Cancer Society Award 0.332676 SEER Cancer Statistics 0.452207	Prospective Investigation Into 0.328734 Lancet Oncol 0.334048 Smoking status 0.321406 gástrico versus 0.335 hombres fumadores 0.333574 Gianfagna F 0.314457 Taylor PR 0.32208 from cancer incidence 0.333557 Cancer Facts 0.332084 Carcinogenic Risks 0.316292 mujeres fumadoras 0.315366 Bouvard V 0.314729 Helicobacter pylori 0.513706 Pereira AK 0.315186 National Cancer Institute 0.508441 antiguos fumadores 0.3326 consumo escaso 0.318979 Investigation Into Cancer 0.373898 Pera G 0.315038 gastric cancer 0.937774 anti-helicobacter pylori therapy 0.32551 systematic review 0.331147 helicobacter pylori eradication 0.395224 Krapcho M 0.325661	CLICK HERE
3527	National Cancer Institute	Html	es	Cáncer de próstata, nutrición y suplementos alimentarios (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos sobre el uso de la nutrición y los suplementos alimentarios para disminuir el riesgo de presentar cáncer de próstata o como tratamiento del mismo.	World Cancer Research 0.326698 Cancer Research Fund 0.313691 Causes Control 0.305123 Sin embargo 0.321932 accessed october 0.306323 productos lácteos 0.431605 vitamina d 0.31442 ayunas polyphenon 0.305303 Preventive Services Task 0.311029 vitamina e 0.30874 Instituto Nacional 0.305332 GEGC Estado Duración 0.307099 ratones tramp 0.382139 among men with 0.325726 Estados Unidos 0.340412 Natl Cancer Inst 0.313037 Ayunas Dosis 0.305586 PDQ Prevención 0.307 men with 0.346832 systematic evidence review 0.313097 prostate tumor 0.309841 cohort studies 0.305885 Cancer Prostate Sweden 0.316805 cohort study 0.307709 Boon H 0.305432	vitamin d 0.306351 dietary calcium 0.324651 diagnosed with 0.308047 Prostate CAncer Therapy 0.319442 Nutr Cancer 0.324876 as risk factors 0.306238 alto consumo 0.312193 Cancer Research 0.341162 Cancer Care 0.312902 Epidemiol Biomarkers Prev 0.355426 Mitrou PN 0.306395 Clin Nutr 0.308257 subsequent risk 0.305051 estudio pcats 0.30523 Services Task Force 0.310689 principales fuentes 0.3052 systematic review 0.306566 risk factor 0.3097 Dietary calcium does 0.306286 prostate cancer 0.981425 Albanes D 0.30581 Polyphenon E 0.333052 risk with specific 0.307113 dairy products 0.430021	CLICK HERE
16822	National Cancer Institute	Html	es	Essiac y Flor Essence (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos sobre el uso de Essiac o Flor Essence como tratamiento para personas con cáncer. Nota: La información contenida en este sumario ya no se actualiza y se ofrece solo con fines de consulta.	Centro Nacional 0.301601 New Hampshire Avenue 0.301144 Drug Administration 0.30071 Flor Essence 0.987323 NCI Best Case 0.302063 modelos animales 0.300855 Indiana University-Purdue University 0.301652 datos bibliográficos pubmed 0.301216 siguientes preguntas 0.300694 productos essiac 0.309556 modelo animal 0.300781 PDQ Essiac 0.318217 National Cancer Institute 0.301364 Royal Cancer Commission 0.301752 Olmo resbaladizo 0.301149 siguientes riesgos 0.300858 Instituto Nacional 0.309533 Salud Complementaria 0.302607	Visuals Online 0.300813 complementarias revisa 0.30115 Physician Data Query 0.304689 Sloan Kettering Cancer 0.301678 Estados Unidos 0.332086 siguientes estudios 0.301314 libre uso 0.301062 distintos resultados 0.300776 únicos efectos 0.301309 ratón p388 0.301025 página manejo 0.300756 ¿El tratamiento 0.301379 Nueva York 0.300871 ¿Los beneficios 0.30071 juntos cam 0.300681 Series Program 0.300695 medicina complementaria 0.332457	CLICK HERE
16854	National Cancer Institute	Html	null	Step 4: NCI Funding Determinations	Funding determinations are made around Oct. 1 each federal fiscal year. These decisions take into account several factors, including Congressional mandates, new scientific opportunities and program priorities when deciding which grants receive funding.			CLICK HERE
17277	National Cancer Institute	Html	null	Cáncer avanzado y quienes cuidan	Si usted cuida a un paciente, puede sentir cansancio y preocupación a medida que se enfrenta al cáncer de su ser querido. Cuidar a alguien con cáncer avanzado trae desafíos y preocupaciones nuevas.			CLICK HERE
17288	National Cancer Institute	Html	es	Personal de atención para la salud	Información sobre el equipo de tratamiento de proveedores de salud que trabajan juntos para ayudar a pacientes con cáncer.	cuáles alimentos 0.989407		CLICK HERE